These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28941549)

  • 1. The Corticostriatal Adenosine A
    Li Z; Chen X; Wang T; Gao Y; Li F; Chen L; Xue J; He Y; Li Y; Guo W; Zheng W; Zhang L; Ye F; Ren X; Feng Y; Chan P; Chen JF
    Biol Psychiatry; 2018 Mar; 83(6):530-541. PubMed ID: 28941549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatopallidal adenosine A
    Li Y; Ruan Y; He Y; Cai Q; Pan X; Zhang Y; Liu C; Pu Z; Yang J; Chen M; Huang L; Zhou J; Chen JF
    Neuropharmacology; 2020 May; 168():108010. PubMed ID: 32061899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
    Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
    Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
    Kase H; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson PJ; Jenner P; Bedard P; Borrelli E; Hauser RA; Chase TN;
    Neurology; 2003 Dec; 61(11 Suppl 6):S97-100. PubMed ID: 14663020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic Activation of Adenosine A2A Receptor Signaling in the Dorsomedial Striatopallidal Neurons Suppresses Goal-Directed Behavior.
    Li Y; He Y; Chen M; Pu Z; Chen L; Li P; Li B; Li H; Huang ZL; Li Z; Chen JF
    Neuropsychopharmacology; 2016 Mar; 41(4):1003-13. PubMed ID: 26216520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain.
    Wei CJ; Augusto E; Gomes CA; Singer P; Wang Y; Boison D; Cunha RA; Yee BK; Chen JF
    Biol Psychiatry; 2014 Jun; 75(11):855-63. PubMed ID: 23820821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation.
    Shen HY; Canas PM; Garcia-Sanz P; Lan JQ; Boison D; Moratalla R; Cunha RA; Chen JF
    PLoS One; 2013; 8(11):e80902. PubMed ID: 24312250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A
    Chen PZ; He WJ; Zhu ZR; E GJ; Xu G; Chen DW; Gao YQ
    Behav Brain Res; 2018 Jul; 347():99-107. PubMed ID: 29501623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatum-projecting prefrontal cortex neurons support working memory maintenance.
    Wilhelm M; Sych Y; Fomins A; Alatorre Warren JL; Lewis C; Serratosa Capdevila L; Boehringer R; Amadei EA; Grewe B; O'Connor EC; Hall BJ; Helmchen F
    Nat Commun; 2023 Nov; 14(1):7016. PubMed ID: 37919287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A
    Simões AP; Machado NJ; Gonçalves N; Kaster MP; Simões AT; Nunes A; Pereira de Almeida L; Goosens KA; Rial D; Cunha RA
    Neuropsychopharmacology; 2016 Nov; 41(12):2862-2871. PubMed ID: 27312408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
    Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
    Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A
    Mouro FM; Köfalvi A; André LA; Baqi Y; Müller CE; Ribeiro JA; Sebastião AM
    Neuropharmacology; 2019 Sep; 155():10-21. PubMed ID: 31103616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A receptors in bone marrow-derived cells but not in forebrain neurons are important contributors to 3-nitropropionic acid-induced striatal damage as revealed by cell-type-selective inactivation.
    Huang QY; Wei C; Yu L; Coelho JE; Shen HY; Kalda A; Linden J; Chen JF
    J Neurosci; 2006 Nov; 26(44):11371-8. PubMed ID: 17079665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating A2A antagonist KW6002 from animal models to parkinsonian patients.
    Chase TN; Bibbiani F; Bara-Jimenez W; Dimitrova T; Oh-Lee JD
    Neurology; 2003 Dec; 61(11 Suppl 6):S107-11. PubMed ID: 14663022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of adenosine A
    Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
    Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of GPR52 enhances the locomotor-stimulating effect of an adenosine A
    Nishiyama K; Suzuki H; Maruyama M; Yoshihara T; Ohta H
    Brain Res; 2017 Sep; 1670():24-31. PubMed ID: 28583861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the adenosine A
    Prasad K; de Vries EFJ; van der Meiden E; Moraga-Amaro R; Vazquez-Matias DA; Barazzuol L; Dierckx RAJO; van Waarde A
    Neuropharmacology; 2024 Apr; 247():109862. PubMed ID: 38325770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatopallidal adenosine A
    Chen JF; Choi DS; Cunha RA
    Neuropharmacology; 2023 Mar; 226():109421. PubMed ID: 36634866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic and acute adenosine A
    Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
    Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.